MedPath

Rocuronium

Generic Name
Rocuronium
Drug Type
Small Molecule
Chemical Formula
C32H53N2O4
CAS Number
143558-00-3
Unique Ingredient Identifier
WRE554RFEZ

Overview

Rocuronium (rapid onset-curonium) is a desacetoxy analogue of vecuronium with a more rapid onset of action. It is an aminosteroid non-depolarizing neuromuscular blocker or muscle relaxant used in modern anaesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. Introduced in 1994, rocuronium has rapid onset, and intermediate duration of action. It is commonly marketed under the trade names Zemuron and Esmeron. The drug is associated with the risk of developing allergic reactions in some high-risk patients, such as those with asthma. However, there was a similar incidence of allergic reactions associated with other non-depolarizing neuromuscular blocking agents. Sugammadex is a γ-cyclodextrin derivative that has been introduced as a novel agent to reverse the action of rocuronium.

Background

Rocuronium (rapid onset-curonium) is a desacetoxy analogue of vecuronium with a more rapid onset of action. It is an aminosteroid non-depolarizing neuromuscular blocker or muscle relaxant used in modern anaesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. Introduced in 1994, rocuronium has rapid onset, and intermediate duration of action. It is commonly marketed under the trade names Zemuron and Esmeron. The drug is associated with the risk of developing allergic reactions in some high-risk patients, such as those with asthma. However, there was a similar incidence of allergic reactions associated with other non-depolarizing neuromuscular blocking agents. Sugammadex is a γ-cyclodextrin derivative that has been introduced as a novel agent to reverse the action of rocuronium.

Indication

For inpatients and outpatients as an adjunct to general anesthesia to facilitate both rapid sequence and routine tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation.

Associated Conditions

  • Muscle fasciculation caused by succinylcholine

Clinical Trials

Login Required

To view more clinical trials, please log in to your account.

Title
Posted
Study ID
Phase
Status
Sponsor
2015/06/15
Not Applicable
Completed
2015/06/12
Phase 2
Completed
2015/06/10
Phase 4
UNKNOWN
2015/06/08
Phase 4
UNKNOWN
2015/05/21
Phase 4
Completed
2015/04/13
Phase 4
Completed
2015/04/07
Phase 4
Withdrawn
2015/03/27
Not Applicable
Completed
2015/03/19
Phase 2
UNKNOWN
2015/03/03
N/A
Completed

FDA Approved Products

Login Required

To view more FDA approved products, please log in to your account.

Product Name
Manufacturer
Route
Strength
Approved
NDC Code

No FDA products found

No FDA products found for this drug

EMA Approved Products

Login Required

To view more EMA approved products, please log in to your account.

Medicine Name
EMA Number
Auth. Holder
Country
Drug Type
Status
Issued
Opinion
Revision

No EMA products found

No EMA products found for this drug

Singapore Approved Products

Login Required

To view more Singapore approved products, please log in to your account.

Product Name
Manufacturer
Dosage Form
Strength
Approved
Approval No.

No Singapore products found

No Singapore products found for this drug

China Approved Products

Login Required

To view more China approved products, please log in to your account.

Product Name
Approval No.
Manufacturer
Dosage Form
Trade Name
Strength
Type
Status
Date
Import

No China products found

No China products found for this drug

Australia Approved Products

Login Required

To view more Australia approved products, please log in to your account.

Product Name
ARTG ID
Sponsor
Status
Reg. Date
Ingredient

No Australia products found

No Australia products found for this drug

© Copyright 2025. All Rights Reserved by MedPath